Literature DB >> 8295466

Human papillomavirus types 11 and 16 detected in nasopharyngeal carcinomas by the polymerase chain reaction.

U Hørding1, H W Nielsen, S Daugaard, H Albeck.   

Abstract

Most nasopharyngeal carcinomas (NPCs) are of the nonkeratinizing or undifferentiated types, which are consistently associated with Epstein-Barr virus (EBV). The smaller group of highly differentiated, keratinizing NPCs seems to be only infrequently associated with EBV. In order to examine whether these rare tumors were related to another oncogenic virus, the authors used the polymerase chain reaction to examine paraffin-embedded sections of 15 keratinizing NPCs for human papillomavirus (HPV) types 6, 11, 16, and 18 genomic sequences. HPV DNA was found in 4 tumors (1 HPV-11-positive, and 3 HPV-16-positive tumors). None of 23 undifferentiated or nonkeratinizing NPCs harbored HPV DNA. The putatively oncogenic HPV type 16 may thus be involved in the carcinogenesis of some EBV-negative keratinizing squamous cell nasopharyngeal carcinomas.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8295466     DOI: 10.1288/00005537-199401000-00018

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  12 in total

Review 1.  Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

Authors:  G Niedobitek
Journal:  Mol Pathol       Date:  2000-10

Review 2.  Epstein-Barr virus infection and human malignancies.

Authors:  G Niedobitek; N Meru; H J Delecluse
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

3.  Human papillomavirus and WHO type I nasopharyngeal carcinoma.

Authors:  Emily J Lo; Diana Bell; Jason S Woo; Guojun Li; Ehab Y Hanna; Adel K El-Naggar; Erich M Sturgis
Journal:  Laryngoscope       Date:  2010-10       Impact factor: 3.325

4.  Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis.

Authors:  Matthew H Stenmark; Jonathan B McHugh; Matthew Schipper; Heather M Walline; Christine Komarck; Felix Y Feng; Francis P Worden; Gregory T Wolf; Douglas B Chepeha; Mark E Prince; Carol R Bradford; Suresh K Mukherji; Avraham Eisbruch; Thomas E Carey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-01       Impact factor: 7.038

Review 5.  A possible role for human papillomaviruses in head and neck cancer.

Authors:  B M Steinberg; T P DiLorenzo
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

6.  Human papillomavirus 16 detected in nasopharyngeal carcinomas in white Americans but not in endemic Southern Chinese patients.

Authors:  Zhixiong Lin; Brian Khong; Shirley Kwok; Hongbin Cao; Robert B West; Quynh-Thu Le; Christina S Kong
Journal:  Head Neck       Date:  2013-10-26       Impact factor: 3.147

7.  HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans.

Authors:  Jessica H Maxwell; Bhavna Kumar; Felix Y Feng; Jonathan B McHugh; Kitrina G Cordell; Avraham Eisbruch; Francis P Worden; Gregory T Wolf; Mark E Prince; Jeffrey S Moyer; Theodoros N Teknos; Douglas B Chepeha; Jay Stoerker; Heather Walline; Thomas E Carey; Carol R Bradford
Journal:  Head Neck       Date:  2010-05       Impact factor: 3.147

8.  Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States.

Authors:  Ilona Argirion; Katie R Zarins; Julie J Ruterbusch; Patravoot Vatanasapt; Hutcha Sriplung; Erlene K Seymour; Laura S Rozek
Journal:  Cancer       Date:  2019-09-16       Impact factor: 6.860

9.  Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population.

Authors:  Snjezana Dogan; Matthew L Hedberg; Robert L Ferris; Tanya J Rath; Adel M Assaad; Simion I Chiosea
Journal:  Head Neck       Date:  2013-06-18       Impact factor: 3.147

10.  Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers.

Authors:  Zeyi Deng; Takayuki Uehara; Hiroyuki Maeda; Masahiro Hasegawa; Sen Matayoshi; Asanori Kiyuna; Shinya Agena; Xiaoli Pan; Chunlin Zhang; Yukashi Yamashita; Minqiang Xie; Mikio Suzuki
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.